The initial findings from the pan-cancer platform SangerBox3.0 revealed that, in the OS analysis, elevated FAM72B expression was associated with a favorable prognosis in THYM, whereas this association was reversed in 16 other cancer types, including GBMLGG, LGG, KIRP, KIPAN, KIRC, LIHC, ACC, KICH, LAML, LUAD, uveal melanoma (UVM), PAAD, sarcoma (SARC), PRAD, mesothelioma (MESO), and ALL (from the TARGET database) (Figure 3A). This evidence concerns the gene FAM72B and cancer.